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ORIGINAL ARTICLE
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ABSTRACT
Anti-cardiolipin (anti-CL) antibodies are autoantibodies which are directed against cell membrane phospholipids.
A significant number of periodontitis patients showed positive for anti-CL antibody. Objective: This study aimed
to determine the periodontal parameters and anti-CL antibodies levels before and after non-surgical periodontal
therapy in chronic periodontitis. Methods: This cross-sectional study had been carried out at Periodontal Clinic,
Hospital Universiti Sains Malaysia, Kubang Kerian, Kelantan, Malaysia. Thirty five chronic periodontitis (CP)
and 39 non-periodontitis (NP) patients underwent clinical periodontal examination at baseline. Plaque index (PI),
gingival index (GI), periodontal pocket depth (PPD), and clinical attachment loss (CAL) were measured. Scaling and
polishing was performed and blood samples were taken for IgG and IgM anti-CL antibodies analysis. Re-evaluation
was performed four weeks after initial therapy. CP patients were re-examined, all periodontal parameters were
recorded and blood samples were taken for reassessment of IgG and IgM anti-CL antibodies. Results: Significant
difference means of PI (p=0.001), GI (p=0.000), PPD (p=0.000) and, CAL (p=0.000) were found between CP and
NP groups. All periodontal parameters were significantly reduced (p≤0.05) after four weeks of therapy. The mean
levels of IgG and IgM anti-CL antibodies at baseline were significantly higher in CP than NP group (IgG=4.46 vs
3.22, p=0.002; IgM=3.28 vs 2.57, p=0.019). No significant difference of the median levels of IgG (p=0.82) and IgM
anti-CL antibodies (p=0.35) following therapy. Conclusion: All periodontal parameters were significantly reduced
following periodontal therapy. Higher level of Anti-CL antibodies in CP indicates stimulation of autoantibodies
production by periodontal infection. Nonetheless no significant changes of this anti-CL antibodies levels despite
significant reduction of the clinical parameters after periodontal therapy.
Key words: periodontal parameters, anti-CL antibodies, chronic periodontitis, non-surgical periodontal therapy
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INTRODUCTION

syndrome (APLS), characterized by thrombosis and
recurrent pregnancy loss.2 A significant number of
periodontitis patients showed positive for anti-CL
antibody, most probably due to bacterial antigens
homologous to the target antigen of anti-CL antibody
on the serum protein β2 glycoprotein-1 (β2GP1),
thus can induce production of anti-CL by molecular
mimicry mechanism.3

Anti-cardiolipin (anti-CL) antibodies are autoantibodies
which are directed against cell membrane phospholipids.
These antibodies are classified as immunoglobulin M
(IgM), immunoglobulin G (IgG), and immunoglobulin
A (IgA) or as β2–glycoprotein dependent or independent
forms1 which have been found in about 15% to 20% of
aggressive and chronic periodontitis patients at higher
concentration than those found in 95% of healthy adult
population.2 These antibodies were typically found in
patients with autoimmune disease such as systemic
lupus erythematosus (SLE) and antiphospholipid

Chronic periodontitis (CP) is an inflammatory disease
due to bacterial infections affecting tissues surrounding
the teeth, periodontal pocket formation, loss of
clinical attachment, and alveolar bone resorption. In
15
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advanced CP, it may lead to tooth mobility, and/or
tooth migration, and tooth loss.4 The role of periodontal
pathogens, notably Porphyromonas gingivalis (P.
gingivalis), in the onset or exacerbation of systemic
diseases has been proposed. P. gingivalis expresses
several virulence factors that promote its survival,
spreading, and sustaining systemic inflammation.5
Schenkein et al. reported increase in IgG anti-CL
antibody titres has been found in 18.9% of periodontitis
patients compared to periodontally healthy subjects
(7.5%).6 They hypothesized that these antibodies
trigger the endothelial cells to produce monocyte
chemotactic protein-1 (MCP-1) which may elucidate
the link between periodontitis and systemic conditions.

in periodontal parameters as well as the decrease in
anti-IgG and IgM anti-CL antibodies levels following
non-surgical periodontal therapy.

METHODS
A prospective study had been conducted at Periodontal
Clinic, Hospital Universiti Sains Malaysia, Kelantan,
Malaysia. A total of 35 chronic periodontitis (CP)
patients and 39 non-periodontitis (NP) subjects with
the age over 18 years old without any medical problem
had participated in this study. The criteria for CP were
those with clinical attachment loss (CAL) of >2mm and
periodontal pocket depth (PPD) of >3mm.4,14 The NP
group were those with healthy periodontium with CAL
of ≤2mm, and PPD of ≤3mm.

Previous studies2,7 have proven that P. gingivalis,
Haemophilus influenza or Neisseria gonorrhoea, and
cytomegalovirus, stimulate the production of anti-CL
antibodies. These pathogens were found to have similar
peptide sequences to the TLRVYK peptide of β2GPI.
Three peptides sequence in the arg-gingipain protease
of P. gingivalis was found to be similar to the TLRVYK
peptide of β2GPI which may induce cross-reactive
autoantibodies in periodontitis patients.2,8 Interestingly,
a number of studies2,3,6 had reported that infection by
periodontal pathogens may stimulate the production of
anti-CL antibodies in periodontitis.

The exclusion criteria for the study includes pregnant
and lactating mothers, smokers, patients who had
chronic medical conditions, patients with history
of trauma or tooth extraction two weeks prior to the
study, patients who received antibiotics and chronic
medications within the past three months, and patients
who underwent periodontal treatment for the past six
months.
Written informed consent was obtained from all
subjects. The study protocol was approved by Human
Research Ethics Committee Universiti Sains Malaysia
[USMKK/PPP/JEPeM (232.3(1)].

In periodontitis, oral hygiene inst r uction and
motivation is the key message for the patients to control
chronic infection. Non-surgical periodontal therapy is
considered the gold standard for the initial treatment
of periodontitis which involves plaque removal, plaque
control, supragingival and subgingival scaling root
planing, as well as adjunctive use of chemical agents.
Other various methods which are used in non-surgical
periodontal therapy include hand instrumentation,
ultrasonic and sonic scalers, and ablative laser therapy.9

Clinical examination
Clinical periodontal examination was performed twice
on CP patients, during the baseline and four weeks after
scaling and polishing. All the periodontal parameters
were recorded. The clinical periodontal examination
was carried out by a calibrated examiner with patient
sitting on dental chair in supine position. Plaque index
(PI), Gingival index (GI), PPD, and CAL were then
measured by using Michigan ‘O’ William’s periodontal
probe which are Plaque index, Gingival index and
Periodontal pocket depth and clinical attachment
loss.15,16

Scaling and polishing removes plaque and calculus
from tooth and root surfaces. Regular removal of these
deposits may reduce gingivitis and prevent progression
to periodontitis.10 Scaling and root planing remain the
essential parts for successful periodontal therapy to
reduce the number of pathogenic bacteria species.11
However, if the periodontal pockets persist at 5mm or
more, root planing is required to remove embedded
calculus, necrotic cementum, and to smoothen the
root surfaces.12 These procedures result in decrease
in inflammation of the periodontium due to a lesser
bacterial load, subsequently leads to beneficial clinical
changes.9 In addition, Gunupati et al.13 had done a
study among chronic periodontitis patients with acute
myocardial infarction. They found that there was a
significant alteration in the concentrations of IgM
(p= 0.008) and IgG (p<0.001) anti-CL antibodies along
with periodontal parameters following non-surgical
periodontal therapy. However, currently the findings
are still controversial. Thus, this study has been carried
out to determine whether there is an improvement

Plaque Index15
PI was used to assess the presence of plaque on tooth
surfaces. and The PI scores as follows: 0) No plaque in
gingival area, 1) Thin plaque layer at gingival margin
and adjacent area of the tooth, only detectable by
scrapping with a probe, 2) Moderate layer of plaque
within the gingival pocket, or on the tooth surface and
along the gingival margin, plaque is visible with the
naked eye, 3) Abundant plaque within the gingival
pocket or on tooth surface and the gingival margin.
Gingival Index16
GI was used to determine the gingival status. The
GI scores can be interpreted as follows: 0) Normal
gingival, absence of gingival inflammation, 1) Mild
16
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Table 1. General characteristics of the subjects (n=74)
Characteristics

Non Periodontitis (n=39)
Mean (SD)

Age (Years)

Chronic Periodontitis (n=35)

Frequency (%)

34.97 (10.88)

Mean (SD)

Frequency (%)

43.23 (11.40)

Gender
Male

16 (41.0%)

16 (45.7%)

Female

23 (59.0%)

19 (54.3%)

37 (94.9%)

31 (88.6%)

2 (5.1%)

4 (11.4%)

Ethnics
Malay
Chinese
*SD: standard deviation
Table 2. The baseline data of periodontal parameters of the subjects (n=74)
Variables

NP (n=39)

CP (n=35)

Mean difference

t-statistic

Mean (SD)

Mean (SD)

(95% CI)

(df)

PI

0.51 (0.34)

0.89 (0.55)

-0.38 (-0.59, -0.16)

-3.5 (55)

0.001

GI

0.47 (0.25)

0.99 (0.48)

-0.52 (-0.70, -0.34)

-5.7 (50)

<0.001

PPD (mm)

1.71 (0.33)

2.66 (0.63)

-0.95 (-1.18, -0.71)

-7.0 (50)

<0.001

p value*

CAL (mm)
0.14 (0.29)
1.16 (1.33)
-1.02 (-1.49, -0.55)
-4.4 (37)
<0.001
*Independent t-test
NP=NonPeriodontitis; CP=Chronic Periodontitis; SD=standard deviation; PI=Plaque index; GI=Gingival index;
PPD=Periodontal pocket depth; CAL= Clinical attachment loss

inflammation – slight change in colour, slight oedema,
no bleeding on pressure. 2) Moderate inflammation –
moderate glazing, redness, oedema and hyperthropy,
bleeding on pressure. 3) Severe inflammation – marked
redness, oedema and hyperthropy, tendency to
spontaneous bleeding.

were then transferred into plain bottles and immediately
transported to the Immunology Laboratory for anti-CL
antibodies analysis.
Anti-CL antibodies analysis
The blood samples were allowed to clot for one hour
at room temperature. Centrifugation was done for
5 minutes at 4,500 rpm using Hettich Zentrifugen
Universal 32 R Centrifuge at 4°C. The sera then were
separated, placed in microcentrifuge tubes and stored
in the refrigerator at -80°C until assayed. The IgG and
IgM anti-CL antibodies levels then were analysed using
commercially available enzyme linked immunosorbent
assay (ELISA) kits according to the manufacture’s
protocol. The normal values of IgG and IgM anti-CL
antibodies were reported as < 10GPL Unit/mL and
<7MPL Unit/mL respectively.

All the periodontal parameters were recorded at four
sites (distal-facial, facial, mesial-facial and lingual/
palatal) of six index teeth (maxillary right first molar,
maxillary right lateral incisor, maxillary left first
premolar, mandibular left first molar, mandibular left
lateral incisor and mandibular right first premolar). The
score for each index tooth was calculated and averaged
for each subjects.
Periodontal pocket depth and clinical attachment
loss
PPD and CAL were measured were determined at six
sites per tooth (mesio-buccal, mid-buccal, disto-buccal,
mesio-lingual-palatal, mid-lingual-palatal, and distolingual-palatal) for all teeth. The total of PPD and CAL
measurements from all teeth then were averaged to get
a mean score for each subject respectively.

Re-evaluation
Full mouth scaling and polishing were performed on
CP patients. However, out of 35 CP patients, only 23
patients were able to turn up after four weeks for reevaluation of periodontal parameters as well as IgG and
IgM anti-CL antibodies levels. This is due to problem in
answering follow up call; some of them claimed to have
forgotten their appointment, and some had problem
in transportation particularly those who stayed in the
rural area. NP subjects were advised for six monthly
routine dental check-up.

Blood samples collection
A standard venepuncture procedure was performed
twice, which is during the baseline and four weeks after
scaling and polishing. Three millilitres of venous blood
was withdrawn during each visit. The blood samples
17
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Table 3. The periodontal parameters at baseline and after 4 weeks of scaling and polishing in chronic periodontitis patients (n=23)
Variables

Baseline

After 4 weeks

Median (IQR)

Median (IQR)

PI

0.75 (0.92)

GI
PPD (mm)

Z statistic*

p-value*

0.42 (0.26)

-2.85

0.005

0.83 (0.75)

0.63 (0.67)

-2.89

0.004

2.36 (0.83)

2.23 (0.71)

-2.86

0.004

CAL (mm)
0.44 (0.69)
0.44 (0.70)
-3.55
<0.001
*Wilcoxon Signed Rank Test
IQR=Interquartile Range; PI=Plaque index; GI=Gingival index; PPD=Periodontal pocket depth; CAL= Clinical attachment loss
Table 4. Comparison of baseline data of the means of IgG and IgM anti-cardiolipin antibodies levels between non-periodontitis
and chronic periodontitis groups (n=74)
Anti-CL antibodies

IgG
(GPL Unit/mL)
IgM

(MPL Unit/ mL)

Anti-CL antibody levels
Mean (SD)

Mean difference
(95% CI)

t-statistic
(df)

p-value*

NP
(n= 39)

CP
(n=35)

3.22 (1.35)

4.46 (1.89)

-1.24
(-1.99, -4.89)

-3.29 (72)

0.002

2.57 (0.91)

3.28 (1.57)

-0.71
(-1.29, -0.12)

-2.40 (72)

0.019

*Independent t- test
NP=Non-Periodontitis; CP=Chronic Periodontitis; SD=Standard Deviation; CI=Confidence Interval; df=degree of freedom

Table 5. The median levels of IgG and IgM anti-cardiolipin antibodies levels at baseline and 4 weeks after scaling and
polishing in chronic periodontitis patients (n=23)
Variables
IgG (GPL Unit/mL)

Before treatment

After treatment

Median (IQR)

Median (IQR)

4.41 (2.49)

IgM (MPL Unit/mL)
2.97 (1.69)
*Wilcoxon Signed Rank Test; IQR: Interquartile Range

Z statistic

p-value*

4.69 (3.39)

-0.228

0.82

3.36 (1.77)

-0.943

0.35

Statistical Analysis
All data were analysed using the Statistical Package for
the Social Sciences (SPSS) version 20.0. Descriptive
statistics of demographic variables were expressed
as frequency and percentage. Independent t-test was
used to compare the baseline data of the means of
periodontal parameters and anti-CL antibodies (IgG
and IgM) levels for NP and CP groups, while Wilcoxon
Signed Rank Test was used to determine the median
(IQR) of periodontal parameters and anti-CL antibodies
(IgG and IgM) at baseline and 4 weeks after scaling
and polishing in CP patients. The p-value of <0.05 was
considered as statistically significant.

of 43.23±11.40 and 34.97±0.88 years respectively.
Majority of the subjects were female (59.0%) and
Malay (94.9%) (Table 1). Table 2 shows the baseline
data of periodontal parameters of NP and CP patients.
Significant differences of the means of PI (p=0.001),
GI (p<0.001), PPD (p<0.001) and CAL (p<0.001) were
found between both groups. In CP patients, the PI, GI,
PPD, and CAL were significantly reduced (p<0.05) at
4 weeks after scaling and polishing (Table 3).
Table 4 shows the baseline levels of IgG and IgM
anti-CL antibodies in NP and CP patients. The mean
levels of IgG and IgM anti-CL antibodies at baseline
were significantly higher in chronic periodontitis than
non-periodontitis group (IgG=4.46 vs 3.22, p=0.002;
IgM=3.28 vs 2.57, p=0.019). Re-evaluation of IgG and
IgM anti-CL antibodies for the 23 CP patients after 4
weeks of scaling and polishing showed slightly increase

RESULTS
Seventy four subjects were recruited at baseline of
the study; 35 CP and 39 were NP with the mean age
18
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in antibodies levels but no significant changes (IgG:
p=0.82 and IgM: p=0.35) compared to the baseline
(Table 5).

in IgG and IgM anti-CL antibodies might be due
to the possibility of ‘immunization’ effect where
the instrumentation induced bacteremia results in
increase antibody production. However, this may
be temporary. Since the duration of measurement of
antibodies during final visit is only four weeks after
scaling and polishing, thus these antibodies levels
may need longer time to be decreased following nonsurgical periodontal therapy. According to Syrjanen
et al.20 transient bacteremia can be directly related to
dental disease and its treatment. Bacteremia frequently
occurs after treatment procedures such as extractions,
scaling, scaling and root planing, periodontal probing,
periodontal surgery, suture removal, orthodontic
treatment, restorative dentistry, non-surgical root canal
treatment. Apart from professional treatment, chewing,
subgingival irrigation, oral hygiene procedures such
as tooth brushing and flossing have been reported to
give rise to bacteremia. However, the results showed
considerable variability due to the techniques used,
timing of blood sample collection, and periodontal
status and identification methods for the isolation of
microorganisms.21 On the contrary, Chaston et al.22
reported there was a significant reduction of IgM
anti-CL antibody following non-surgical periodontal
therapy but not for IgG anti-CL antibodies.

DISCUSSION
In this study, the mean age of chronic periodontitis
patients was 43.23 years, which was older than nonperiodontitis subjects (34.97 years). This ref lects
periodontitis is common in older age. Khan et al.17
and Kiany and Hedayati18 reported the mean age of
CP patients in their study were 43.9 and 40.55 years
respectively, which were almost similar with our
study. Most patients were female and from Malay
ethnic group.
Significant difference means of PI (p= 0.001), GI
(p<0.001), PPD (p<0.001) and, CAL (p<0.001) were
found between NP and CP groups. In fact, the means
of PI (p= 0.005), GI (p= 0.004), PPD (p= 0.004) and CAL
(p=0.000) in CP patients were found to be reduced
significantly after full mouth scaling and polishing.
As mentioned previously, non-surgical periodontal
therapy reduces inf lammation and subsequently
improve the periodontal parameters.9 These findings
are consistence with previous studies 18, 19 which
reported a significant reduction in PI, GI, PPD, and
CAL following non-surgical periodontal therapy. In
addition, a number of studies also reported the similar
significant reduction of PI, GI, PPD and CAL following
non-surgical periodontal therapy involving scaling and
root planing.3,13,18

Our study shows no significant changes of the median
IgG and IgM anti-CL antibodies levels at baseline and
four weeks after scaling and polishing in CP patients
(IgG: p=0.82 and IgM: p=0.35). This may indicate
longer time interval is needed for the reduction of
anti-CL levels following periodontal therapy. However,
several studies reported contradictory findings. Kiany
and Hedayati18 found that there was a significant
difference of mean levels of IgM (p=0.003) and IgG
(p= 0.001) anti-CL antibodies before and after six
weeks of non-surgical periodontal therapy. In 2011,
Gunupati et al.13 reported there was a significant
changes in IgG anti-CL antibodies (P<0.001) and IgM
anti-CL antibodies (p=0.008) in CP patients with acute
myocardial infarction following one month of nonsurgical periodontal therapy.

Our study shows IgG and IgM anti-CL antibodies in
CP patients were significantly higher compared to NP
subjects, although the levels were within the normal
range based on the kit manufacturer. The results are
consistent with the finding from previous studies2, 8 that
reported a significant number of periodontitis patients
have demonstrated elevated serum concentration of
anti-CL antibodies. The increase in anti-CL antibodies
in our patients most probably due to production of
autoantibodies triggered by periodontal pathogens.
As mentioned previously, anti-CL antibodies are
commonly found in in patients with SLE and APLS2
and can increase in some infectious diseases.7 These
pro-thrombotic auto-antibodies are also associated with
adverse pregnancy outcomes such as fetal involution,
prematurity, low birth weight with cardiovascular
sequelae such as atherosclerosis, stroke and myocardial
infarction. All of these conditions are remarkable similar
to systemic condition associated with periodontitis.2
Since infectious diseases may induce production of
anti-CL antibodies, it is hypothesized that CP patients
may have increased anti-CL antibodies levels.

In this study, the levels of anti-CL antibodies in CP
patients were increased compared to NP group. The
most possible cause of increase in anti-CL antibodies in
CP patients is due to periodontal infections. Although
the levels of anti-CL antibody in periodontitis patients
are mostly lower than those currently recommended in
the classification criteria for diagnosis of APS2 , these
antibodies have nevertheless been shown to enhance
cytokine release from human vascular endothelial cells6.
Therefore, this will further promote the inflammatory
process in chronic periodontitis. Periodontal infections
triggered the production of anti-CL antibodies by
molecular mimicry mechanism. Molecular mimicry
occurs when a self-antigen (protein β2GP1) is similar
to antigens from a microorganisms (antigens with
peptide sequences of periodontal pathogens) or

The median levels of IgG and IgM anti-CL antibodies
were increased at four weeks following full mouth
scaling in chronic periodontitis patients. The increase
19
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other source in the environment. 23 Furthermore,
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